Carolinas HealthCare System

Research and Clinical Trials

Title   Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV: The REALM Study
Brief Description   Observational study of patients who are initiating or modifying their therapy for chronic hepatitis B. They will receive either entecavir or another standard of care HBV nucleoside/tide analogue.
Who may be Eligible   Patients with chronic HBV infection, and are appropriate for a study regimen of nucleoside/tide monotherapy
Specialty/Disorder   Hepatitis B
IRBĀ Number   CHS1-07-379
PrincipalĀ Investigator   Russo, Mark
For More Information, Contact   Gale  W.  Groseclose , RN
Phone:  (704) 355-4875  Fax:  (704) 355-8147 
Email:  gale.groseclose@carolinashealthcare.org
Address:  Carolinas Medical Center 1000 Blythe Boulevard Medical Education Building, Ste. 103 Charlotte, NC 28203
About Carolinas HealthCare System
Who We Are
Leadership
Community Benefit
Corporate Financial Information
Diversity & Inclusion
Annual Report
Foundation
Patient Links
Pay Your Bill
Hospital Pre-Registration
Patient Rights
Privacy
Financial Assistance
Quality & Value Reports
Insurance
Careers
Join Carolinas HealthCare System
Physician Careers

For Employees
Carolinas Connect
Connect with Us
Watch Carolinas HealthCare on YoutubeFollow Carolinas HealthCare on TwitterLike Carolinas HealthCare on FacebookContact Carolinas HealthCareJoin Carolinas HealthCare on LinkedInGo to our mobile website.